Remove 2023 Remove Medical Remove Telehealth Remove Utilities
article thumbnail

Predicting Likelihood of Missed Appointments in Primary Care [Health care informatics]

Annals of Family Medicine

Setting Family medicine clinics in an academic medical center in southcentral Pennsylvania. Population Studied Adult patients scheduled for in-person or telehealth visits between 01/2019-06/2023. Intervention/Instrument A multiclass random forest (RF) method for risk prediction was utilized.

article thumbnail

CDRH Seeks Public Comment on How to Increase Patient Access to At-Home Use Medical Technologies

FDA Law Blog

Cato — On June 1, CDRH announced that it is seeking public comment on questions regarding how CDRH can facilitate access to medical technologies designed for use outside of traditional clinical settings, particularly in the home. At-home medical technologies include, but are not limited to, monitoring and wearable devices (e.g.,

Medical 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telemedicine in a Post-Pandemic World: Joe Rotella, Brooke Calton, Carly Zapata

GeriPal

This DEA is taking 6-months to consider how to move forward vis a vis restrictions and requirements for telehealth in a post-pandemic world. See the AAHPM Legislative Action Center [link] Write to the DEA, with guidance from AAHPM’s comments to the DEA March 2023. Now is the time to act, dear listeners! Stories trump data. Eric: Yeah.

article thumbnail

Senator Durbin Has Questions About FDA’s “Operational Capacity” to Oversee DTC Prescription Drug Advertising Amid Workforce Reductions – Don’t We All?

FDA Law Blog

Senator Durbins letter references a January 2023 study from the Journal of the American Medical Association, which found that more than two-thirds of drugs advertised on television were considered to have low therapeutic value. Healthier populations are more productive.